ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,450,106 | -10.3% | 1,343,040 | +1.6% | 1.01% | -6.1% |
| Q2 2023 | $40,639,510 | -14.2% | 1,322,040 | +0.5% | 1.08% | -18.4% |
| Q1 2023 | $47,391,700 | -10.8% | 1,315,340 | -2.1% | 1.32% | -6.8% |
| Q4 2022 | $53,109,911 | -1.6% | 1,343,740 | +0.0% | 1.42% | -13.2% |
| Q3 2022 | $53,975,000 | -4.7% | 1,343,340 | -0.2% | 1.63% | +2.0% |
| Q2 2022 | $56,609,000 | +7.9% | 1,346,540 | 0.0% | 1.60% | +24.7% |
| Q1 2022 | $52,461,000 | -3.7% | 1,346,540 | -1.5% | 1.28% | +2.4% |
| Q4 2021 | $54,496,000 | +30.2% | 1,367,540 | +18.1% | 1.25% | +23.2% |
| Q3 2021 | $41,844,000 | +41.7% | 1,157,840 | +60.8% | 1.02% | +49.3% |
| Q2 2021 | $29,523,000 | – | 720,240 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |